Two papers relying on hospital records of COVID-19 patients have been retracted because the company that purportedly analyzed the raw data won’t allow their validity to be independently validated.
By Charles PillerScience’s COVID-19 reporting is supported by the Pulitzer Center.In the first big research scandal of the COVID-19 era, The Lancet and The New England Journal of Medicine (NEJM) today retracted two high-profile papers after a company declined to make the underlying data for both available for an independent audit, following questions being raised about the research.
The Lancet paper, which claimed an antimalarial drug touted by President Donald Trump for treatment of COVID-19 could cause serious harm without helping patients, had